ArticleACS omega2026
G‑Quadruplex and i‑Motif Structures in the
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple sclerosis is a fatal neurodegenerative disease that progresses by eroding the myelin sheath and exposing the neuron, leading to neuronal degradation and death. While multiple sclerosis remains without an effective treatment or cure, studies have identified genes that are dysregulated in multiple sclerosis patients and predicted to be involved with disease progression. These genes are primarily involved in controlling DNA methylation, a process required for regulating gene expression that is critical for cellular health. Having identified potential genetic risk factors, current research focuses on how to manipulate the expression of these genes, offsetting DNA methylation errors in patients by targeting DNA secondary structure formation. Serine hydroxymethyltransferase 1 (SHMT1) is a key player in DNA methylation and was determined to be upregulated in multiple sclerosis patients. Here, we characterized hybrid 3 + 1 G-quadruplex (GQ) and i-motif (iM) structures in the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.